Close

Rhabdomyosarcoma related Products

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Overview

Rhabdomyosarcoma in children is a rare cancerous tumor that arises in the soft tissue of the body, includes muscles, fibrous tissues, tendons, blood vessels, and synovial tissues. There are two major types of rhabdomyosarcoma: Embryonal and Alveolar. The former is diagnosed most often in children younger than 5, or even be present at birth, which often affects the head and neck, bladder, vagina or prostate and testicles, usually with an abnormality of chromosome 11. The later type, which is seen at any age, often affects the large muscles of the arms, legs and trunk. The chromosome material rearrangement between chromosomes 2 and 13 may be the possible reason, which involves the disfunction of two genes, PAX3 and FKHR. For unclear mechanism, females are affected slightly less than males.

Signs, symptoms and treatments

Similar to other cancers, the rhabdomyosarcoma symptoms vary depending on the location of the tumor, which may include: a lump or swelling that does not go away, constipation, numbness, headaches, protrusion of the eye, bleeding from the nose, vagina or rectum. Treatment for rhabdomyosarcoma may be carried out alone or in combination. Today, with the most advance surgical technique, tumor could be removed as much as possible. Meanwhile, chemotherapy, radiation therapy, lumbar puncture or/and autologous bone marrow transplant can also be very helpful to get good clinical therapeutic effect.

Loading...
Products
Global Services
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.